News & Events

9.09.20

NBC Nightly News: COVID-19 Devastates Latino Community Along The Southern Border

9.09.20

SF Business Times: Startup Looked To Change Vaccine, Drug Clinical Trials - Then Covid Changed It

9.02.20

New York Post: Man Who Lost 7 Relatives To COVID-19 First To Try Experimental Vaccine In US

9.02.20

MSN: First American Dosed In Oxford's Final Trial For Its COVID-19 Vaccine

9.02.20

Today Show: Labor Day Brings New Concerns About Coronavirus Resurgence In The Fall

9.01.20

NBC Nightly News: Phase 3 Clinical Trials For Oxford Coronavirus Vaccine Begins

9.01.20

CBS News (National): AstraZeneca Starts Phase Three Vaccine Trials

9.01.20

First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida

8.11.20

Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial

8.5.20

Covid-19 Vaccine Trials Have a Problem: Minority Groups Don’t Trust Them

7.16.20

Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials

7.7.20

Headlands Research Acquires CNS Global Site Leaders JEM Research Institute and Toronto Memory Program.

6.16.20

Headlands Research Is Seeking Experienced Research Professionals For Their Newest Research Center In Metro Orlando.

6.10.20

When a Drug Study Abruptly Ends, Volunteers Are Left to Cope - Dr. Sharon Cohen

4.16.20

Managing Trials One Month Into the COVID-19 Pandemic

3.17.20

Headlands Coronavirus Efforts - Proactively Addressing the Challenge

11.20.19

Q&A: Tackling Underrepresentation In Clinical Trials

11.19.19

Mergermarket: Headlands has Active Pipeline

11.13.2019

San Francisco Business Journal: KKR-backed startup on hunt to buy clinical trial sites to boost study quality, diversity

11.13.2019

Headlands Research Acquires Six Clinical Research Sites As It Seeks to Transform the Clinical Trial Process

Headlands Research 2019-2020 Conference Appearances